Pharmacokinetic interactions of flunixin meglumine and enrofloxacin in dogs

American Journal of Veterinary Research

Volumn 66, Issue 7, 2005, Pages 1209-1213

  Ogino, Tomoe ^a   Mizuno, Yasuharu ^a   Ogata, Tomoko ^a   Takahashi, Yoshiyuki ^a  

^a National Veterinary Assay Laboratory   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN; FLUNIXIN MEGLUMINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CLONIXIN; DOGS; DRUG INTERACTIONS; FEMALE; FLUOROQUINOLONES; HALF-LIFE; MALE;

ANIMALIA; CANIS FAMILIARIS;

EID: 23844540462     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.1209     Document Type: Article

References (21)

1. Vancutsem PM, Babish JG, Schwark WS. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 1990;80:173-186.
2. Prescott JF, Yielding KM. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can J Vet Res 1990;54:195-197.
3. Walker RD, Stein GE, Hauptman JG, et al. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Vet Res 1992;53:2315-2319.
4. Hannan PCT, Windsor GD, de Jong A, et al. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob Agents Chemother 1997;41:2037-2040.
5. Tasker S, Helps CR, Day MJ, et al. Use of a Taqman PCR to determine the response of Mycoplasma haemofelis infection to antibiotic treatment. J Microbiol Methods 2004;56:63-71.
6. Anderson KL, Smith AR, Shanks RD, et al. Efficacy of flunixin megulumine for the treatment of endotoxin-induced bovine mastitis. Am J Vet Res 1986;47:1366-1372.
7. Whittem T, Firth EC, Hodge H, et al. Pharmacokinetic interaction between repeated dose phenylbutazone and gentamicin in the horse. J Vet Pharmacol Ther 1996;19:454-459.
8. EL-Banna HA. Pharmacokinetic interactions between flunixin and sulphadimidine in horses. Dtsch Tierarztl Wochenschr 1999;106:400-403.
9. Rantala M, Kaartinen L, Välimäki E, et al. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J Vet Pharmacol Ther 2002;25:251-258.
10. Hardie EM, Hardee GE, Rawlings CA. Pharmacokinetics of flunixin meglumine in dogs. Am J Vet Res 1985;46:235-237.
11. Küng K, Riond JL, Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Phrmacol Ther 1993;16:462-468.
12. Odensvik K, Johansson IM. High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug. Am J Vet Res 1995;56:489-495.
13. Schneider M, Thomas V, Boisrame B, et al. Pharmacokinetics of marbofloxacin in dogs after oral and parental administration. J Vet Pharmacol Ther 1996;19:56-61.
14. Stegelmeier BL, Bottoms GD, Denicola DB, et al. Effects of flunixin meglumine in dogs following experimentally induced endotoxemia. Cornell Vet 1988;78:221-230.
15. Bregante MA, Saez P, Aramayona JJ, et al. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. Am J Vet Res 1999;60:1111-1116.
16. Coakley M, Peck KE, Taylor TS, et al. Pharmacokinetics of flunixin megulumine in donkeys, mules, and horses. Am J Vet Res 1999;60:1441-1444.
17. Jensen RC, Fischer JH, Cwik MJ. Effect of age and status on pharmacokinetics of flunixin meglumine in Thoroughbreds. Am J Vet Res 1990;51:591-594.
18. Rao GS, Ramesh S, Ahmad AH, et al. Effects of endotoxin-induced fever and probenecid on disposition of enrofloxacin and its active metabolites ciprofloxacin after intravascular administration of enrofloxacin in goats. J Vet Pharmacol Ther 2000;23:365-372.
19. Neuman M. Comparative pharmacokinetics parameters of new systemic fluoroquinolones: a review. Chemioterapia 1987;6:105-112.
20. Miyazaki Y, Horii Y, Ikenaga N, et al. Possible active transport mechanism in pharmacokinetics of flunixin-meglumin in rabbits. J Vet Med Sci 2001;63:885-888.
21. Dow SW, Rosychuk RAW, McChesney AE, et al. Effects of flunixin and flunixin plus prednisone on the gastrointestinal tract of dogs. Am J Vet Res 1990;51:1131-1138.